Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Invested Capital (2016 - 2026)

Champions Oncology (CSBR) has 15 years of Invested Capital data on record, last reported at $4.2 million in Q4 2025.

  • For Q4 2025, Invested Capital rose 512.33% year-over-year to $4.2 million; the TTM value through Oct 2025 reached $4.2 million, up 512.33%, while the annual FY2025 figure was $3.8 million, 298.21% up from the prior year.
  • Invested Capital reached $4.2 million in Q4 2025 per CSBR's latest filing, up from $3.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $9.2 million in Q1 2022 and bottomed at -$2.1 million in Q1 2024.
  • Average Invested Capital over 5 years is $4.7 million, with a median of $5.1 million recorded in 2023.
  • Peak YoY movement for Invested Capital: crashed 141.05% in 2024, then skyrocketed 1165.66% in 2025.
  • A 5-year view of Invested Capital shows it stood at $8.1 million in 2021, then grew by 13.64% to $9.2 million in 2022, then crashed by 98.99% to $93000.0 in 2023, then surged by 632.26% to $681000.0 in 2024, then surged by 512.33% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $4.2 million in Q4 2025, $3.5 million in Q3 2025, and $3.8 million in Q2 2025.